Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells
about
Shikonin induces apoptosis and inhibits migration of ovarian carcinoma cells by inhibiting the phosphorylation of Src and FAK.High Expression of Pyruvate Kinase M2 is Associated with Chemosensitivity to Epirubicin and 5-Fluorouracil in Breast Cancer.In vitro synergistic efficacy of conjugated linoleic acid, oleic acid, safflower oil and taxol cytotoxicity on PC3 cells.Natural Compounds As Modulators of Non-apoptotic Cell Death in Cancer Cells.Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancerNatural compounds regulate glycolysis in hypoxic tumor microenvironment.Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways.Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis.Efficacy of Shikonin against Esophageal Cancer Cells and its possible mechanisms in vitro and in vivo.Shikonin reduces tamoxifen resistance through long non-coding RNA uc.57.IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer.PKM2 in carcinogenesis and oncotherapy.Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2.RNA-seq transcriptome analysis of breast cancer cell lines under shikonin treatment.Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition.Natural Products for the Management and Prevention of Breast Cancer.Shikonin sensitizes wild‑type EGFR NSCLC cells to erlotinib and gefitinib therapy
P2860
Q34993806-D64AB523-5AD8-44A2-B297-48CBEAA5B965Q36190132-7EF3844D-A788-4C69-A9E3-1E5DC6E10904Q38964875-56084369-19FC-4E7E-BE21-654C1D65A787Q39214221-988E8AF9-6A1F-4311-A0E9-0E63A5824512Q42339119-8BEC8D32-FCFB-4364-922F-345594C223CCQ42876285-52755EFB-19AE-4380-871F-D93C127EA798Q46976280-99AEECD3-F54C-49C0-B5A2-32870AA4AAFBQ47094780-22F654DF-83B6-4E7F-AA03-F452DA169154Q47108219-46CDEA58-97C8-47B6-B990-4279A1954F99Q47113944-9E0BFFFB-B9C0-4633-B5AC-113B8BDD1852Q47116282-188E6562-B39A-41F2-89FE-D67B26398881Q47153446-27767BFD-3391-44E6-9C89-F5735404DC56Q48113904-CB4F8ED7-98D1-44EA-9E7F-69F68C9259E4Q49475580-6F404181-EE7B-4BBB-9223-63BC0545E6C0Q52098926-48ED271C-4987-4242-9635-17716BA3D053Q55043805-BBE5B9A2-929C-4C29-BF27-5FC1E8390B30Q58800891-ECEC00AB-51B6-4E94-90B1-2C4B7AEC585B
P2860
Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells
@ast
Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells
@en
Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells
@nl
type
label
Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells
@ast
Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells
@en
Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells
@nl
prefLabel
Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells
@ast
Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells
@en
Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells
@nl
P2093
P2860
P1433
P1476
Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells
@en
P2093
Kasey Jackson
Runhua Shi
Wenjuan Li
Yunfeng Zhao
P2860
P304
P356
10.1371/JOURNAL.PONE.0094079
P407
P577
2014-01-01T00:00:00Z